BURLINGAME, Calif., March 16, 2022 /PRNewswire/ -- Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today opened its new facility in Newark, California, where it will ...

BURLINGAME, Calif., Feb. 2, 2022 /PRNewswire/ -- Vector Laboratories, the pioneer of innovative proteomic and glycomic solutions, today announced the addition of Katy Miles to its Board of Directors, ...

Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, announced ...

BURLINGAME, CA — October 18, 2017 — Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, announced today (Oct. 18) the ...

NEWARK, Calif.--(BUSINESS WIRE)--Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and ...

“Other approaches to removing tissue autofluorescence have been ineffective, laborious, and can even reduce the immunofluorescence signal of the sample. With our new TrueVIEW Kit, we improve the ...

NEWARK, Calif.--(BUSINESS WIRE)--Vector Laboratories, the pioneer of innovative proteomic and glycomic research solutions, today announced the acquisition of Quanta BioDesign, the inventor of discrete ...

GTCR, a leading private equity firm, today announced that it has completed a strategic equity investment in Vector Laboratories, Inc. (“Vector” or the “Company”), through GTCR’s previously established ...

The new kit combines Vector's validated lectins with Navinci's in situ PLA technology to gain insights beyond protein expression The Glysite™ Explorer in situ PLA Glycan Detection Kit is a fully ...

Vector Laboratories, a manufacturing partner of reagents and critical components for the development and production of life sciences tools, diagnostics, and clinical-stage biotherapeutics, announced ...